Last reviewed · How we verify
NCT03611374
Regional Anesthesia for Cardiothoracic Enhanced Recovery (RACER) Study
NA trial testing Bilateral Erector Spinae Plane Block (ESPB) in Congenital Heart Defect in 38 participants. Completed in 6 April 2023.
6 April 2023
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 7 June 2019 |
| Primary completion | 6 April 2023 |
| Estimated completion | 6 April 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Bilateral Erector Spinae Plane Block (ESPB)
Conditions studied
- Congenital Heart Defect — all drugs for Congenital Heart Defect →
- Congenital Heart Disease — all drugs for Congenital Heart Disease →
- Anesthesia, Local — all drugs for Anesthesia, Local →
- Opioid Use — all drugs for Opioid Use →
Sponsor
Stanford University
Who can join
Adults 0 to 99, any sex, with Congenital Heart Defect or Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The erector spinae plane block is a novel regional anesthetic technique that allows for analgesia of the thorax and abdomen with a peripheral nerve block. The goals of this study are to determine if bilateral erector spinae plane blocks (ESPB) after sternotomy for congenital heart repair in high risk children and adults can decrease outcomes such as duration of postoperative mechanical ventilation (MV), perioperative opioid consumption, days in the intensive care unit (ICU) and length of stay (LOS).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03611374
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Congenital Heart Defect
Currently open trials in the same condition.
- NCT05698277 — Automated Fetal Cardiac Function in Babies Affected by Heart Diseases · recruiting
- NCT04271358 — Peer Coaching Intervention in Young Adults With Congenital Heart Disease · NA · active not recruiting
- NCT04437069 — Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making · NA · active not recruiting
- NCT04106479 — NIRS in Congenital Heart Defects - Correlation With Echocardiography · recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03611374 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03611374.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing